{"title":"印第安人糖尿病足溃疡患者下肢截肢的差异","authors":"Lyndsay A. Kandi, Tze-Woei Tan","doi":"10.15761/VDT.1000176","DOIUrl":null,"url":null,"abstract":"It is a well-documented declaration that the Native American (NA)/ American Indian (AI) population is disproportionately affected by many chronic conditions. Among the chronic and often fatal ailments, diabetes mellitus (DM) is a prevailing diagnosis [1]. According to the 2017 American Diabetes Association, DM is responsible for significant deaths and is a substantial cost to society at $327 billion USD in the United States (US) [2]. Complications of DM include peripheral artery disease (PAD), a macrovascular complication, and peripheral neuropathy (PN), a microvascular condition, which in turn cascade into other adverse health outcomes [3,4]. Impaired vascular flow and loss of sensitivity to the extremities, particularly to the feet, likewise increases risk of diabetic foot ulceration (DFU) [3,4]. As a consequence of an infected foot ulceration and subsequent osteomyelitis or gangrene, patients may undergo lower extremity amputation (LEA) [4,5]. DFU not only limits mobility and causes pain and discomfort, but foot ulceration may even increase mortality rates and reduce life expectancy [6,7]. The rate of recurrence for DFU within 1 year is roughly 40%, about 60% within 3 years, and 65% within 5 years [8].","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"103 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Disparities in lower extremity amputation among native americans with diabetic foot ulcerations\",\"authors\":\"Lyndsay A. Kandi, Tze-Woei Tan\",\"doi\":\"10.15761/VDT.1000176\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"It is a well-documented declaration that the Native American (NA)/ American Indian (AI) population is disproportionately affected by many chronic conditions. Among the chronic and often fatal ailments, diabetes mellitus (DM) is a prevailing diagnosis [1]. According to the 2017 American Diabetes Association, DM is responsible for significant deaths and is a substantial cost to society at $327 billion USD in the United States (US) [2]. Complications of DM include peripheral artery disease (PAD), a macrovascular complication, and peripheral neuropathy (PN), a microvascular condition, which in turn cascade into other adverse health outcomes [3,4]. Impaired vascular flow and loss of sensitivity to the extremities, particularly to the feet, likewise increases risk of diabetic foot ulceration (DFU) [3,4]. As a consequence of an infected foot ulceration and subsequent osteomyelitis or gangrene, patients may undergo lower extremity amputation (LEA) [4,5]. DFU not only limits mobility and causes pain and discomfort, but foot ulceration may even increase mortality rates and reduce life expectancy [6,7]. The rate of recurrence for DFU within 1 year is roughly 40%, about 60% within 3 years, and 65% within 5 years [8].\",\"PeriodicalId\":206117,\"journal\":{\"name\":\"Vascular Diseases and Therapeutics\",\"volume\":\"103 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular Diseases and Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15761/VDT.1000176\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Diseases and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/VDT.1000176","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Disparities in lower extremity amputation among native americans with diabetic foot ulcerations
It is a well-documented declaration that the Native American (NA)/ American Indian (AI) population is disproportionately affected by many chronic conditions. Among the chronic and often fatal ailments, diabetes mellitus (DM) is a prevailing diagnosis [1]. According to the 2017 American Diabetes Association, DM is responsible for significant deaths and is a substantial cost to society at $327 billion USD in the United States (US) [2]. Complications of DM include peripheral artery disease (PAD), a macrovascular complication, and peripheral neuropathy (PN), a microvascular condition, which in turn cascade into other adverse health outcomes [3,4]. Impaired vascular flow and loss of sensitivity to the extremities, particularly to the feet, likewise increases risk of diabetic foot ulceration (DFU) [3,4]. As a consequence of an infected foot ulceration and subsequent osteomyelitis or gangrene, patients may undergo lower extremity amputation (LEA) [4,5]. DFU not only limits mobility and causes pain and discomfort, but foot ulceration may even increase mortality rates and reduce life expectancy [6,7]. The rate of recurrence for DFU within 1 year is roughly 40%, about 60% within 3 years, and 65% within 5 years [8].